{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:09Z","timestamp":1793212089007,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41395-018-0176-7","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T12:01:58Z","timestamp":1530187318000},"page":"1669-1677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":177,"title":["Continuous Anti-TNF\u03b1 Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)"],"prefix":"10.14309","volume":"113","author":[{"given":"Maxime","family":"Luu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Benzenine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Doret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Barkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Degand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Quantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bardou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-22-20210302","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3748\/wjg.v17.i22.2696","article-title":"Inflammatory bowel disease in pregnancy.","volume":"17","author":"Beaulieu","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R3-22-20210302","doi-asserted-by":"crossref","first-page":"e0129567","DOI":"10.1371\/journal.pone.0129567","article-title":"Inflammatory bowel disease and risk of adverse pregnancy outcomes.","volume":"10","author":"Boyd","year":"2015","journal-title":"PLoS ONE"},{"key":"R4-22-20210302","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2010.02.014","article-title":"Crohns disease is a risk factor for preterm birth.","volume":"8","author":"Stephansson","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-22-20210302","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/1471-0528.13946","article-title":"Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes.","volume":"123","author":"Shand","year":"2016","journal-title":"BJOG"},{"key":"R6-22-20210302","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/MIB.0000000000000802","article-title":"Adverse pregnancy outcomes among women with inflammatory bowel disease: a population-based study from England.","volume":"22","author":"Abdul Sultan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R7-22-20210302","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ajg.2016.254","article-title":"The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.","volume":"111","author":"de Lima-Kararagiannis","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R8-22-20210302","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1572-0241.2002.05543.x","article-title":"Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.","volume":"97","author":"Dominitz","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R9-22-20210302","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2013.09.061","article-title":"Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.","volume":"146","author":"Ban","year":"2014","journal-title":"Gastroenterology"},{"key":"R10-22-20210302","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jbspin.2013.09.001","article-title":"Recommendations for using TNFalpha antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health.","volume":"80","author":"Goeb","year":"2013","journal-title":"Joint Bone Spine"},{"key":"R11-22-20210302","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease.","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R12-22-20210302","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy.","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"R13-22-20210302","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2015-309321","article-title":"Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.","volume":"65","author":"de Lima","year":"2016","journal-title":"Gut"},{"key":"R14-22-20210302","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ajg.2008.71","article-title":"Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy.","volume":"104","author":"Kane","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R15-22-20210302","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/apt.14040","article-title":"The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease.","volume":"45","author":"Seow","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-22-20210302","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2036.2011.04617.x","article-title":"High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.","volume":"33","author":"Zelinkova","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-22-20210302","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0016-5085(12)60561-7","article-title":"PIANO: A 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy.","volume":"142","author":"Mahadevan","year":"2012","journal-title":"Gastroenterology"},{"key":"R18-22-20210302","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1741-7015-11-174","article-title":"Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review.","volume":"11","author":"Nielsen","year":"2013","journal-title":"BMC Med"},{"key":"R19-22-20210302","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ajg.2012.430","article-title":"Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease.","volume":"108","author":"Casanova","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R20-22-20210302","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1542\/peds.2014-0054","article-title":"Anti-TNF-alpha therapy may cause neonatal neutropenia.","volume":"134","author":"Guiddir","year":"2014","journal-title":"Pediatrics"},{"key":"R21-22-20210302","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/ecco-jcc\/jjw083","article-title":"Maternal inflammatory bowel disease during pregnancy is not a risk factor for long-term morbidity of the offspring.","volume":"10","author":"Freud","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R22-22-20210302","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2016.11.004","article-title":"Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-alpha use in females with immune mediated diseases; a systematic review and meta-analysis.","volume":"76","author":"Komaki","year":"2017","journal-title":"J Autoimmun"},{"key":"R23-22-20210302","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/pubmed\/fds057","article-title":"Advantages and limitations of using national administrative data on obstetric blood transfusions to estimate the frequency of obstetric hemorrhages.","volume":"35","author":"Quantin","year":"2013","journal-title":"J Public Health"},{"key":"R24-22-20210302","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1016\/j.vaccine.2013.09.052","article-title":"Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measlesmumpsrubella immunization.","volume":"31","author":"Hanf","year":"2013","journal-title":"Vaccine"},{"key":"R25-22-20210302","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.","volume":"318","author":"Lemaitre","year":"2017","journal-title":"J Am Med Assoc"},{"key":"R26-22-20210302","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2008.10.044","article-title":"Maternal age, multiple birth, and extremely low birth weight infants.","volume":"154","author":"Vohr","year":"2009","journal-title":"J Pediatr"},{"key":"R27-22-20210302","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/ajg.2010.105","article-title":"A novel risk score to stratify severity of Crohns disease hospitalizations.","volume":"105","author":"Ananthakrishnan","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R28-22-20210302","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection.","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"R29-22-20210302","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/00365521.2013.812141","article-title":"Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-alpha therapy during pregnancy: three-center study.","volume":"48","author":"Bortlik","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"R30-22-20210302","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0960327114550882","article-title":"Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with metaanalysis.","volume":"34","author":"Mozaffari","year":"2015","journal-title":"Hum Exp Toxicol"},{"key":"R31-22-20210302","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","article-title":"A meta-analysis on the influence of inflammatory bowel disease on pregnancy.","volume":"56","author":"Cornish","year":"2007","journal-title":"Gut"},{"key":"R33-22-20210302","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cgh.2012.10.024","article-title":"Effects of discontinuing antitumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.","volume":"11","author":"Zelinkova","year":"2013","journal-title":"Clin Gastroenterol Hepatol Assoc"},{"key":"R34-22-20210302","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/apt.12833","article-title":"Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.","volume":"40","author":"Seirafi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R35-22-20210302","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/j.crohns.2012.07.020","article-title":"Chicken pox infection in a three months old infant exposed in utero to Adalimumab.","volume":"7","author":"Johnsson","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R36-22-20210302","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index.","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"R37-22-20210302","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"R38-22-20210302","first-page":"240","article-title":"The clinical use of corticosteroids in pregnancy.","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum Reprod Update"},{"key":"R39-22-20210302","doi-asserted-by":"crossref","first-page":"j1039","DOI":"10.1136\/bmj.j1039","article-title":"Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study.","volume":"356","author":"Travers","year":"2017","journal-title":"BMJ"},{"key":"R40-22-20210302","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.steroids.2016.05.012","article-title":"Effects of antenatal glucocorticoids on the developing brain.","volume":"114","author":"Carson","year":"2016","journal-title":"Steroids"},{"key":"R41-22-20210302","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohns disease: more than 5 years of follow-up in the TREAT registry.","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0176-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0176-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0176-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:46:21Z","timestamp":1786542381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1038\/s41395-018-0176-7","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}